4:08 PM ET
8-K
Business Update
Bolt Biotherapeutics Business Update
Bolt Biotherapeutics entered into a second lease amendment for its Redwood City facilities, accelerating the lease expiration date to December 31, 2027, or earlier upon a strategic transaction. The company paid $1.0 million upfront and agreed to a $4.5 million termination payment upon a future corporate transaction, significantly reducing its ongoing rent and operating expense obligations.
- Counterparty
- HCP LS Redwood City LLC
- Term
- through Dec 2027